In a recent study posted on bioRxiv* Preprint server, researchers evaluated the efficiency of lipid nanoparticles against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). study: Delivery...
Antibodies induced after coronavirus disease 2019 (COVID-19) vaccination or SARS-CoV-2 infection have the ability to cross-neutralize the variant of concern (VOC). It is declining. However, antibodies...
In a recent study posted on bioRxiv* Preprint server, researchers found the original Wuhan-Hu 1 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) strain, Alpha, Delta, Delta-plus...
In a recent study posted on bioRxiv* Preprint server, researchers investigated changes in levels of cyclins and cyclin-dependent kinases (CDKs) in host cells caused by coronavirus...
Recent studies submitted to the Centers for Disease Control and Prevention (CDC) Weekly morbidity and mortality report (MMWR) Evaluated Effectiveness of Severe Acute Respiratory Syndrome Coronavirus...
In a recent study posted on medRxiv* Preprint server, researchers found that almost 7 months after vaccination, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BNT162b 23rd...
Recent Comments